Castle Biosciences' Change in Cash fell 6460.0% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.4 million, marking a year-over-year decrease of 35168.63%. This contributed to the annual value of $20.9 million for FY2024, which is 18656.41% up from last year.
As of Q3 2025, Castle Biosciences' Change in Cash stood at $3.3 million, which was down 6460.0% from -$7.5 million recorded in Q2 2025.
Castle Biosciences' 5-year Change in Cash high stood at $24.8 million for Q4 2024, and its period low was -$139.0 million during Q3 2022.
Over the past 5 years, Castle Biosciences' median Change in Cash value was -$8.1 million (recorded in 2023), while the average stood at -$17.1 million.
In the last 5 years, Castle Biosciences' Change in Cash tumbled by 259248.35% in 2022 and then soared by 30182.76% in 2024.
Castle Biosciences' Change in Cash (Quarter) stood at -$33.5 million in 2021, then surged by 66.52% to -$11.2 million in 2022, then soared by 167.82% to $7.6 million in 2023, then surged by 224.89% to $24.8 million in 2024, then tumbled by 86.57% to $3.3 million in 2025.
Its Change in Cash stands at $3.3 million for Q3 2025, versus -$7.5 million for Q2 2025 and -$30.0 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value